Nanobiotix S.A. - Sponsored ADR

NBTX Healthcare Biotechnology

21.30 0.93 −4.18%
Market cap
$1.1B
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
3.40
Beneish M
n/a
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Cash and Short Term Investments
22.17 56.88 41.61 39.31 136.11 99.29 43.61 81.48 53.82 59.68
Receivables
5.29 5.90 6.15 0.01 0.07 4.41 0.11 0.98 3.22 2.42
Other current assets
0.85 1.20 1.26 12.34 6.89 10.81 11.45 12.07 9.47 8.90
Total current assets
28.31 63.99 49.02 51.66 143.07 110.10 55.16 94.53 66.51 71.00
Property, Plant, Equpment (Net)
2.56 3.60 3.31 10.51 9.43 9.68 7.50 6.77 5.99 5.17
Long-Term Investments
0.53 0.60 — 0.59 0.58 0.61 0.31 0.32 0.44 0.49
Goodwill and Intangible Assets (Total)
0.00 0.16 0.12 0.18 0.02 0.00 0.00 0.01 0.01 0.01
Long-term assets (Other)
0.35 0.55 0.44 — — — — — — —
Total non-current assets
— — — 11.29 10.03 10.30 7.81 7.10 6.44 5.67
Total Assets
31.75 — 52.90 62.95 153.10 120.40 62.97 101.62 72.95 76.66
Accounts Payable
4.60 6.20 7.48 8.70 8.12 7.67 10.14 19.74 21.68 10.32
Current Part of Debt
1.14 0.93 0.57 — — — — — — —
Current Revenue (Deferred)
— — — — — 19.54 0.06 0.14 0.07 0.05
Other current liabilities
2.76 3.87 5.07 7.37 13.63 16.38 29.77 34.10 42.03 54.69
Total current liabilities
8.68 11.27 13.33 16.07 21.75 43.59 39.97 53.98 63.77 65.06
Long Term Debt (Total)
4.82 4.77 23.01 — — — — — — —
Non-current Liabilities (Other)
0.18 0.28 0.38 49.02 50.86 45.12 51.50 49.64 80.28 107.18
Total non-current liabilities
— — — 49.02 50.86 45.12 51.50 49.64 80.28 107.18
Total liabilities
13.69 16.32 36.73 65.09 72.61 88.71 91.47 103.62 144.05 172.25
Additional Paid In Capital
— — — 171.52 292.13 302.60 269.47 338.48 338.42 355.71
Common Stock (Net)
0.50 0.71 0.68 0.75 1.18 1.24 1.10 1.53 1.54 1.64
Retained Earnings
(23.03) — — (57.02) (38.37) (55.61) (60.10) (42.97) (73.73) (27.11)
Treasury Stock
— — — 0.19 0.22 0.24 0.24 0.25 0.25 0.26
Shareholders Equity (Other)
— — — (117.68) (174.85) (217.05) (239.46) (299.59) (337.85) (426.35)
Common Equity (Total)
18.06 52.59 16.17 (2.14) 80.50 31.70 (28.49) (2.00) (71.10) (95.58)
Shareholders Equity (Total)
18.06 52.59 16.17 (2.14) 80.50 31.70 (28.49) (1.99) (71.10) (95.58)
Shareholders Equity and Liabilities (Total)
— — — 62.95 153.10 120.40 62.97 101.62 72.95 76.66
Shares (Common)
— — — 22.42 34.43 34.83 34.88 47.13 47.43 48.41
Shareholders Equity (Tangible)
— — — (2.32) 80.47 31.69 (28.50) (2.00) (71.11) (95.59)
Net Debt
(16.20) (51.18) (18.03) (39.31) (136.11) (99.29) (43.61) (81.48) (53.82) (59.68)
Total Debt
5.97 5.70 23.59 50.03 60.47 52.30 56.56 — — —

Fold the line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated 28 Sep 2026